Performa HargaHarga kembali 1 minggu-37.25%
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)0.53
Harga Terendah (52 Minggu)0.32
Latar Belakang Perusahaan
Perusahaan bioteknologi yang mengembangkan terapi untuk manajemen nyeri dan pengobatan mual serta muntah akibat kemoterapi.
Summary
Valuation Information
Current PE Ratio (TTM)-1.83
Forward PE Ratio46.95
Current Price to Book Value7.67
Current Price to Sales0.38
EV to Revenue1.26
EV to EBITDA35.04
PEG Ratio-
Per Share
Current EPS (Annualized)-0.18
Diluted EPS (TTM)-0.18
Revenue Per Share0.85
Current Book Value Per Share0.04
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA-8165000
Profit Margin-0.205
Operating Margin-0.137
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
Feed
Perfoma Harga
Statistik Utama
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
